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Abstract 
Magnetic resonance imaging was used to study swelling dynamics and hydrogel formation 
of xanthan tablets with or without Pentoxifylline drug in water and HCl pH 1.2 media at two 
different ionic strengths. Significant changes were observed only in the erosion front positions 
leading to different hydrogel thicknesses. The impact of the drug on the hydrogel thickness 
was found to be dependent on the medium conditions at high enough drug amount. The drug 
does not change the hydrogel thickness in water medium, whereas in acid medium the 
presence of the drug results in thinner hydrogel. The increased ionic strength in water medium 
also leads to formation of the thinner hydrogel layer in tablets with high enough drug content, 
while the effect of NaCl in HCl pH 1.2 medium is very small.   
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1. Introduction 
Matrix tablets made of hydrophilic polymers like xanthan are widely used for controlled 
delivery of drugs. On contact with water or body fluids the outer surface of these tablets 
hydrates and swells, forming a hydrogel coat around the dry central core. This complex 
hydrogel coat around d the dry central core regulates the penetration of body fluids into the 
tablet on one side and the drug release kinetics on the other [1, 2]. Therefore, the penetration 
of medium into the polymer tablet, the polymer swelling behaviour and the drug dissolution 
and diffusion out of the tablet are the key factors to understand the drug release mechanism 
from polymer matrices.  
The various layers formed within matrix tablets during hydration are important in 
controlling the release of the drug. The central dry core is a glassy state polymer. As the 
medium ingresses into the tablet, a penetration front between the dry glassy and the hydrated 
glassy polymer appears. As the proportion of the medium increases, the polymer glass 
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 transition temperature is reduced to below the system temperature, and the hydrated glassy 
polymer is progressively transformed to a rubbery state (hydrogel). The interface between the 
glassy and rubbery states is called the swelling front. The polymer chains swell as they 
hydrate, and the eroding front appears as an interface between the swollen tablet and the bulk 
medium [3, 4]. 
Xanthan is a well-known biopolymer that adopts a double-strand helix conformation in its 
native state [5]. In solution the rigid helix-coil structure transforms into flexible coils whose 
stability and physical properties are strongly influenced by pH and the ionic environment [6].  
In our study an impact on the xanthan hydrogel formation by highly soluble model drug 
Pentoxifylline was investigated. Since it is known that pH and the ionic environment 
influence the xanthan hydrogel formation and these parameters progressively change in the 
gastrointestinal tract, the impact on the xanthan hydrogel formation by the model drug was 
studied in media with different pH and ionic strengths.  
2. Materials and Methods 
2.1. Materials 
Xanthan (XAN) with a molecular weight of 2x10
6
 was obtained from Sigma-Aldrich Chemie, 
Germany. Pentoxifylline (PF), a methylxanthine derivative, (MW = 278.31) with a solubility 
in water at 37°C of 191 mg/ml was supplied by Krka, d.d., Slovenia. To study the dependence 
of hydrogel thickness and drug delivery on pH and ionic strength µ of media, four different 
media were used: purified H2O and HCl at pH 1.2 according to Ph. Eur. 6th Ed and the same 
media with increased ionic strength (11.7 g of NaCl per 1000 ml of each medium). The final 
ionic strengths of the media were: H2O (µ = 0 M), H2O + NaCl (µ = 0.2 M), HCl pH 1.2 (µ = 
0.08 M), and HCl pH 1.2 + NaCl (µ = 0.28 M). The ionic strength µ was calculated as 
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 where n is number of all ions in the solution, ci is the molar concentration 
measured in mol/l (M) and zi is the charge number of ion i.  
 2.2 Preparation of matrix tablets 
Xanthan and the drug (PF) were mixed homogeneously using a laboratory model drum 
blender. Three kinds of circular flat-faced tablets were prepared by direct compression (SP 
300, Kilian & co., Cologne, Germany) to form tablets with diameter 12 mm and crushing 
strength 100 N ± 10 N: tablets with XAN:PF = 3:1 with m = 0.4 g and thickness of 3.23 mm, 
tablets with XAN:PF = 1:1 with m = 0.7 g and thickness of 4.83 mm and tablets without drug  
with m = 0.5 g and thickness of 4.00 mm. For MRI experiments tablets were covered with a 
double layer of an impermeable hydrophobic polymer, leaving only one circular surface 
exposed for medium penetration.  
2.3 MR imaging of xanthan tablets during swelling  
MR images were recorded at room temperature on a TecMag Apollo (USA) MRI 
spectrometer with a superconducting 2.35 T horizontal bore magnet (Oxford Instruments, 
UK) equipped with gradients and RF coils for MR microscopy (Bruker, Germany). To be able 
to accurately determine penetration, swelling and erosion fronts during tablets swelling two 
different MRI methods were used. The 2D MR images were taken using a standard multi-
echo pulse sequence [7] with an echo time (TE) of 6.2 ms, number of echoes (N) 50 and a 
repetition time (TR) of 200 ms. The field of view was 50 mm with in-plane resolution of 200 
µm and slice thickness of 3 mm. To measure short T2 times (tablet at room humidity, hydrated 
glassy polymer and hydrogels with high polymer concentration), a one dimensional single 
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 point imaging (1D SPI) T2 mapping sequence was used [8]. A single point on the free 
induction decay was sampled at the encoding time tp = 0.17 ms after the radiofrequency 
detection pulse  = 20o. TR was 200 ms and the inter-echo time was varied from 0.3 ms to 10 
ms. The field of view was 45 mm with in-plane resolution of 350 µm.  
To follow changes within the tablets during swelling, 2D MRI and 1D SPI sequences were 
used after medium was added to a tablet inserted in a container. For MRI experiments tablets 
were covered with an impermeable hydrophobic polymer, leaving only one circular surface 
exposed for medium penetration. A tablet at room humidity was used as reference. The first 
MR image was taken approximately 10 minutes after the tablet came in contact with medium 
and then every 30 minutes for 15 hours. The measurements were repeated at least three times 
for each kind of tablets and each medium.  
T2 mapping was obtained at different swelling times. T2 values at each point in the 2D MR 
image were determined by fitting the signal intensities at different echo times to a single-
exponential function. In the regions with T2 values shorter than 5 ms, T2 was obtained from 
1D SPI measurements.  
3. Results and Discussions 
To follow the polymer swelling a combination of different MRI techniques was used for 
accurately determining moving fronts as described in ref. [9]. The border between dry and 
hydrated glassy xanthan – the penetration front – was determined from 1D SPI signal 
intensity profiles. The swelling front, where xanthan is transformed from a glassy to a rubbery 
state (hydrogel formation), was determined from T2 profiles. The erosion front was obtained 
from signal intensity profiles of T1-weighted spin-echo MR images. Since the incorporated 
drug changes the relaxation times, the T2 values at which the xanthan is transformed from a 
glassy to a rubbery state was determined to be 2.7 ms for the XAN tablets and 2.1 ms for the 
XAN tablets containing the drug. 
Figure 1: The positions of erosion, swelling and penetration fronts together with the increase of hydrogel 
layer thickness (difference between the erosion and swelling front positions) formed in xanthan matrix tablets 
during swelling for pure xanthan tablets and for xanthan tablets with incorporated Pentoxifylline drug in water 
and in acid media. Each point represents the mean value of at least three measurements and error bars show ±SD. 
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 Fig. 1 shows the penetration, swelling and erosion fronts positions as well as hydrogel 
thickness at different swelling times for all three types of tablets in water and HCl pH 1.2 + 
NaCl media. The highly soluble drug does not change the position of the swelling front in any 
media, while it slightly slows the medium penetration in the tablet irrespective of the media 
pH, ionic strength and the drug content. Slower medium penetration can be explained by high 
solubility of the PF drug that uses some water to dissolve. The polymer erosion does not 
change within the experimental error at lower drug content, i.e. for the XAN:PF=3:1 tablets, 
in any of the media used in the study. At higher drug content (XAN:PF = 1:1) the polymer 
erosion is strongly influenced by the media pH and ionic strength. In water medium the drug 
does not change the polymer erosion rate. In water medium with added NaCl (µ = 0.2 M) the 
erosion is slightly slowed by the drug (data not shown). The impact of the drug on erosion is 
more pronounced in acid media, where the increase of the ionic strength does not further 
change the erosion rate. The hydrogel thickness (the difference between the erosion and 
swelling front positions) of the xanthan tablets follows the differences of the erosion front 
movement (Fig. 1). The hydrogel thickness dependence on the pH and ionic strength does not 
change with the incorporated drug. It decreases as follows: H2O > H2O+NaCl>HCl pH 1.2> 
HCl pH 1.2+NaCl for all three types of the tablets. However, since the drug does not 
influence the erosion in water medium where the hydrogel is the thickest and it decreases the 
hydrogel layer in the other three media the differences in the hydrogel thicknesses between 
different media increase at higher drug content (Fig. 2). 
 
 
 
 
 
Figure 2: The hydrogel thicknesses 
of xanthan tablets without drug 
(open symbols) and of XAN:PF = 
1:1 tablets (solid symbols) in 
different media. Each point 
represents the mean value of at least 
three measurements and error bars 
show ±SD. 
 
 
 
 
 
The impact of a drug on the hydrogel formation has been studied for different polymers. In 
highly amylose starch with 10 wt % of drug no effect on swelling was observed owing to too 
low drug content [10], while the higher swelling rate was observed at higher drug contents 
[11]. In a non-ionic semi-synthetic polymer HPMC the studies with high soluble excipient 
(mannitol) and low soluble excipient (dicalcium phosphate) in ratio of 40% HPMC and 60% 
drug were performed [12]. It was shown that the hydrogel thickness slightly increases in the 
case of mannitol and significantly decreases in the case of dicalcium phosphate. The similar 
results, i.e. the increase of polymer hydration in the case of highly soluble drug antipyrine and 
its decrease when the polymer was loaded with low soluble drug hesperetin was observed in 
tablets made of HPMC or PVP in water [13]. In the case of HPMC tablets loaded with a 
tetracycline hydrochloride swelled in an acid medium (pH 2), the hydrogel thickness increases 
with the increase of the amount of the loaded drug [14, 15]. The wider hydrogel layer was 
also observed in the presence of drug in hydroxypropylcellulose (LH41) [16]. The studies of 
the effect of a high molecular weight drug peptide on the medium uptake kinetics in a 
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 poly(glycolide-co-lactide) showed that the drug slows the buffer uptake [17]. Different 
impacts of the drug on the hydrogel thickness can be attributed to different hydrogel 
structures formed by different polymers and different drug-polymer interactions that can alter 
medium penetration and polymer chain mobility causing different swelling behaviour. It has 
been previously shown that the medium penetration, the hydrogel formation rates, the drug 
release, as well as the medium pH and ionic strengths dependence on the hydrogel formation 
are different for ionic-polymer xanthan than for non-ionic polymers like HPMC [9]. Our 
study shows that not only the amount of the incorporated drug that has to be high enough to 
influence the polymer swelling, but also the medium properties (pH and ionic strength) are 
important at least in the case of ionic-polymer xanthan. 
4. Conclusions 
The studies showed that the incorporated hydrophilic drug has some influence on the 
positions of the moving fronts at high enough drug content. However, the drug influence does 
not depend only on the drug content, but also on the medium pH and ionic strength. The 
medium penetration into the tablet is slightly slowed by the drug regardless of the medium 
conditions, while the drug has no effect on the hydrogel formation. The largest impact of the 
drug is observed in the erosion front position which is reflected in different thicknesses of the 
hydrogel layers. The hydrogel thickness depends on the amount of the incorporated drug as 
well as on the medium conditions.  
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